100 related articles for article (PubMed ID: 2389956)
21. [Neoadjuvant intraarterial chemotherapy with dose intensification in locally advanced breast cancer].
Takatsuka Y; Shin E; Fukuda K; Mishima H; Tono T; Yagyuu T; Kobayashi K; Kikkawa N
Gan To Kagaku Ryoho; 1995 Sep; 22(11):1546-8. PubMed ID: 7574755
[TBL] [Abstract][Full Text] [Related]
22. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
23. Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapy.
Shen J; Valero V; Buchholz TA; Singletary SE; Ames FC; Ross MI; Cristofanilli M; Babiera GV; Meric-Bernstam F; Feig B; Hunt KK; Kuerer HM
Ann Surg Oncol; 2004 Sep; 11(9):854-60. PubMed ID: 15313733
[TBL] [Abstract][Full Text] [Related]
24. [A clinical trial of neoadjuvant intraarterial chemotherapy for the treatment of locally advanced breast cancer].
Takatsuka Y; Shin E; Kikkawa N
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1523-5. PubMed ID: 8854796
[TBL] [Abstract][Full Text] [Related]
25. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
26. Randomized trial comparing neo-adjuvant versus adjuvant chemotherapy in operable locally advanced breast cancer (T4b N0-2 M0).
Deo SV; Bhutani M; Shukla NK; Raina V; Rath GK; Purkayasth J
J Surg Oncol; 2003 Dec; 84(4):192-7. PubMed ID: 14756429
[TBL] [Abstract][Full Text] [Related]
27. Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer.
Swain SM; Sorace RA; Bagley CS; Danforth DN; Bader J; Wesley MN; Steinberg SM; Lippman ME
Cancer Res; 1987 Jul; 47(14):3889-94. PubMed ID: 3036348
[TBL] [Abstract][Full Text] [Related]
28. [Effect of intra-arterial infusion of adriamycin on locally advanced primary breast cancer--third report. Clinical Study Group of Adriamycin for Breast Cancer in Japan].
Yayoi E; Terasawa T; Koyama H; Sakai K; Kurokawa Y; Asaishi K; Morimoto T; Takashima S; Takatsuka Y; Yoshida K
Gan To Kagaku Ryoho; 1988 Jun; 15(6):1873-80. PubMed ID: 3382239
[TBL] [Abstract][Full Text] [Related]
29. [A comparative study of preoperative intra-arterial infusion chemotherapy and transcatheter arterial chemo-embolization in patients with locally advanced breast cancer].
Takatsuka Y; Akagi K; Kawahara K; Okamura Y; Sugitachi A; Kawahara T
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2501-4. PubMed ID: 3415261
[TBL] [Abstract][Full Text] [Related]
30. Long-term follow-up of the Stockholm randomized trials of postoperative radiation therapy versus adjuvant chemotherapy among 'high risk' pre- and postmenopausal breast cancer patients.
Rutqvist LE; Johansson H
Acta Oncol; 2006; 45(5):517-27. PubMed ID: 16864164
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
32. Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma.
Hsu C; Huang CS; Chao TY; Lu YS; Bu CF; Chen MM; Chang KJ; Cheng AL
Cancer; 2002 Nov; 95(10):2044-50. PubMed ID: 12412156
[TBL] [Abstract][Full Text] [Related]
33. First-line intra-arterial chemotherapy (IAC) with epirubicin and mitoxantrone in locally advanced breast cancer.
Fiorentini G; Tsetis D; Bernardeschi P; Varveris C; Rossi S; Kalogeraki A; Athanasakis E; Dentico P; Kanellos P; Biancalani M; Almarashdah S; Zacharioudakis G; Saridaki Z; Chalkiadakis G; Xynos E; Zoras O
Anticancer Res; 2003; 23(5b):4339-45. PubMed ID: 14666649
[TBL] [Abstract][Full Text] [Related]
34. [Therapeutic effect of stage III breast cancer--comparative study of preoperative intra-arterial infusion chemotherapy and non-infusion therapy].
Masuoka H; Asaishi K; Toda K; Okazaki M; Okazaki Y; Hayasaka H; Miyake H; Mori M
Gan To Kagaku Ryoho; 1989 May; 16(5):2067-73. PubMed ID: 2543329
[TBL] [Abstract][Full Text] [Related]
35. [Intra-arterial infusion chemotherapy with adriamycin for the treatment of locally advanced breast cancer--studies of serum and tissue concentrations of adriamycin].
Takatsuka Y; Imamotoh H; Tsuchiyama M; Numata N; Kawahara T
Gan To Kagaku Ryoho; 1982 May; 9(5):880-7. PubMed ID: 7184432
[TBL] [Abstract][Full Text] [Related]
36. [Intra-arterial infusion chemotherapy for locally advanced breast cancer using implantable reservoir connected with catheter inserted in recurrent radial artery].
Ashino Y; Goto H; Oigawa K; Yamaguchi I
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1968-71. PubMed ID: 1877840
[TBL] [Abstract][Full Text] [Related]
37. [Intra-arterial infusion chemotherapy for breast cancer].
Matsumoto Y; Terakado H; Ikawa M; Hamada E; Watanabe Y; Nakasato S; Takaki S; Murata M; Miura T
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1526-8. PubMed ID: 8854797
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB.
Kim R; Osaki A; Tanabe K; Toge T
Oncol Rep; 2004 Jun; 11(6):1265-72. PubMed ID: 15138565
[TBL] [Abstract][Full Text] [Related]
39. [Intra-arterial chemotherapy in locally advanced or recurrent breast neoplasms].
Morandi C; Colopi S; Cantore M; Molani L; Calzona C; Reggiani G; Amadori M; Smerieri F; Pellecchi G
Radiol Med; 1996; 92(1-2):101-4. PubMed ID: 8966246
[TBL] [Abstract][Full Text] [Related]
40. Endoluminal resection for sessile neoplasia in the GI tract is associated with a low recurrence rate and a high 5-year survival rate.
Wang AY; Ahmad NA; Zaidman JS; Brensinger CM; Lewis JD; Long WB; Kochman ML; Ginsberg GG
Gastrointest Endosc; 2008 Jul; 68(1):160-9. PubMed ID: 18577483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
